Medication effects on the gut microbiome in allo-HCT.

Robinson, Welles; Gertz, E Michael; Greten, Tim F; Ruppin, Eytan

Robinson, Welles; Gertz, E Michael; Greten, Tim F; Ruppin, Eytan.

Afiliação

Robinson W; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA; Surgery Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Gertz EM; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Greten TF; Gastrointestinal Malignancies Section, Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA; Liver Cancer Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.
Ruppin E; Cancer Data Science Laboratory, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA. Electronic address: eytan.ruppin@nih.gov.

Cell ; 186(12): 2520-2523, 2023 06 08.

Article em En | MEDLINE | ID: mdl-37295398

ABSTRACT

ABSTRACT

Decreased gut microbiome diversity has been associated with negative outcome in allogeneic hematopoietic stem cell transfer (HCT). A study published in this issue of Cell identifies associations between non-antibiotic drug administration, microbiome state transitions, and response to HCT, highlighting the potential impact of such drugs on microbiome and HCT outcome.

Assuntos

Microbioma Gastrointestinal; Doença Enxerto-Hospedeiro; Transplante de Células-Tronco Hematopoéticas; Microbiota; Humanos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Microbiota / Microbioma Gastrointestinal / Doença Enxerto-Hospedeiro Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google